Corstasis Therapeutics Announces Allowance of a New Patent and Development Updates for Subcutaneous Programs RSQ-786 and RSQ-789

businesswire

Corstasis Therapeutics Announces Allowance of a New Patent and Development Updates for Subcutaneous Programs RSQ-786 and RSQ-789 – NEWSnet – News… as it used to be

More Press Releases

April 29, 2026

DXD Capital Provides Wealth Managers Access to Its Latest Self Storage Fund via iCapital Marketplace

April 29, 2026

URME United Reaches Stage 7, Expands Infrastructure and Launches Wealth & Legacy Division

April 29, 2026

73% of Cybersecurity Vendors Are Invisible to ChatGPT, GrackerAI Benchmark Finds as AI Search Reshapes B2B

April 29, 2026

Corstasis Therapeutics Announces Allowance of a New Patent and Development Updates for Subcutaneous Programs RSQ-786 and RSQ-789

DXD Capital Provides Wealth Managers Access to Its Latest Self Storage Fund via iCapital Marketplace

URME United Reaches Stage 7, Expands Infrastructure and Launches Wealth & Legacy Division

73% of Cybersecurity Vendors Are Invisible to ChatGPT, GrackerAI Benchmark Finds as AI Search Reshapes B2B

Straight Shooter Plumbing and Rooter Expands National Footprint with New Knoxville, Tennessee Location